{
    "ticker": "CVRX",
    "name": "Cardiovascular Systems, Inc.",
    "description": "Cardiovascular Systems, Inc. (CSI) is a medical device company focused on advancing the treatment of vascular disease. Founded in 2004, CSI specializes in developing innovative products for the treatment of coronary and peripheral artery diseases. The company's flagship products include the Diamondback 360\u00ae Orbital Atherectomy System and the Stealth 360\u00b0\u00ae Catheter System, both of which are designed to treat calcified lesions in arteries, improving blood flow and reducing the risk of complications associated with vascular diseases. CSI aims to enhance patient outcomes through its cutting-edge technologies and commitment to clinical research. The company is headquartered in St. Paul, Minnesota, and has established a significant presence in the cardiovascular market, working closely with healthcare professionals to provide solutions tailored to patients' needs. CSI's mission is to improve the quality of life for patients suffering from vascular diseases by providing safe and effective treatment options, while also focusing on reducing healthcare costs through innovative medical devices. With a strong emphasis on R&D, CSI continues to explore new technologies and approaches to further enhance its product offerings in the field of interventional cardiology.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "St. Paul, Minnesota, USA",
    "founded": "2004",
    "website": "https://www.cardiovascularsystems.com",
    "ceo": "Scott S. Ward",
    "social_media": {
        "twitter": "https://twitter.com/CSI_Medical",
        "linkedin": "https://www.linkedin.com/company/cardiovascular-systems-inc/"
    },
    "investor_relations": "https://investors.cardiovascularsystems.com",
    "key_executives": [
        {
            "name": "Scott S. Ward",
            "position": "CEO"
        },
        {
            "name": "Kevin J. Kline",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Interventional Cardiovascular Devices",
            "products": [
                "Diamondback 360\u00ae Orbital Atherectomy System",
                "Stealth 360\u00b0\u00ae Catheter System"
            ]
        }
    ],
    "seo": {
        "meta_title": "Cardiovascular Systems, Inc. | Innovating Vascular Disease Treatment",
        "meta_description": "Explore Cardiovascular Systems, Inc., a leader in medical devices for vascular disease treatment, dedicated to improving patient outcomes with cutting-edge technologies.",
        "keywords": [
            "Cardiovascular Systems",
            "Vascular Disease",
            "Medical Devices",
            "Atherectomy",
            "Coronary Disease"
        ]
    },
    "faq": [
        {
            "question": "What does Cardiovascular Systems, Inc. specialize in?",
            "answer": "CSI specializes in developing innovative medical devices for the treatment of vascular disease."
        },
        {
            "question": "Where is the headquarters of Cardiovascular Systems located?",
            "answer": "The headquarters of Cardiovascular Systems is in St. Paul, Minnesota, USA."
        },
        {
            "question": "When was Cardiovascular Systems founded?",
            "answer": "Cardiovascular Systems was founded in 2004."
        },
        {
            "question": "What are some of CSI's main products?",
            "answer": "Some of CSI's main products include the Diamondback 360\u00ae Orbital Atherectomy System and the Stealth 360\u00b0\u00ae Catheter System."
        }
    ],
    "competitors": [
        "ABT",
        "SYK",
        "BSX",
        "MDT"
    ],
    "related_stocks": [
        "JNJ",
        "ZTS",
        "ISRG",
        "HOLX"
    ]
}